Register Login

SIONNA THERAPEUTICS, INC. (SION)

Director Fleming Harold Edward 🟢 acquired 17.3K shares (1 derivative) of Sionna Therapeutics, Inc. (SION) at $36.73 Transaction Date: Jun 17, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot June 18, 2026, 11:18 p.m.

    🔍 Fleming Harold Edward (Director)

    Company: Sionna Therapeutics, Inc. (SION)

    Report Date: 2026-06-17

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 17,340

    Detailed Transactions and Holdings:

    • Acquired 17,340 shares of Non-Qualified Stock Option (right to buy) at $36.73 per share (Derivative)
      Date: 2026-06-17 | Code: A | Expires: 2036-06-16 | equity_swap_involved: 0 | shares_owned_after: 17,340.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The Reporting Person has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Issuer's board of directors. As such, the Reporting Person disclaims beneficial ownership of, and all right, title and interest in, the option and the shares issuable upon exercise thereof.
    • F2: This option vests in full upon the earlier of June 17, 2027 or the date of the next annual meeting of Sionna Therapeutics, Inc., subject to the Reporting Person's continued service on such vesting date.

Search

News categories